• Air cargo carrier has also set up a dedicated rapid response team to handle requests for vaccine transport

Dubai, UAE - Emirates SkyCargo is stepping up its readiness to handle the logistical complexities of distributing a potential COVID-19 vaccine globally by creating the world’s first dedicated airside cargo hub for the vaccine in Dubai. The air cargo carrier is taking a global leadership position by announcing that it will be re-opening its Emirates SkyCentral DWC cargo terminal in Dubai South to serve as a dedicated anchor hub for cold chain storage and distribution of the vaccine.

Watch a video about Emirates SkyCargo setting up the world's largest GDP compliant airside hub for COVID-19 vaccine distribution. 

The freight division of Emirates has also set up a dedicated rapid response team to coordinate requests from the various partners involved in the international vaccine distribution ecosystem and to streamline the carrier’s response to vaccine transportation requests.

HH Sheikh Ahmed bin Saeed Al Maktoum, Emirates Chairman and Chief Executive said: "Dubai is well positioned to serve as a gateway and distribution hub for COVID-19 vaccines to the rest of the world. We have the infrastructure and logistics connections, and a geographic location that puts markets representing more than two-thirds of the world’s population within an 8-hour flying radius. Over the years, through our continuous investment in capabilities and processes for the transport of temperature sensitive pharmaceuticals, Emirates SkyCargo has managed to position Dubai amongst major global pharmaceutical customers as the year-round preferred point of transit for their valuable cargo. Setting up a dedicated airside hub for COVID-19 vaccines is a keystone project harnessing our network, reach and competencies to positively impact the lives of people around the world."

World’s first dedicated airside hub for COVID-19 vaccine

Emirates SkyCargo’s vaccine hub in Dubai South will be the largest dedicated airside facility in the world for COVID-19 vaccines. The Dubai hub will allow the air cargo carrier to fly in vaccines from manufacturing sites globally, store and prepare shipments for regional and global distribution.

Emirates SkyCentral DWC has over 4,000 square metres of temperature controlled GDP certified dedicated pharma storage area allowing for large scale storage and distribution of the potential COVID-19 vaccines. Overall, it is estimated that the facility can hold around 10 million vials of vaccine at a 2-8 degrees Celsius temperature range at any one point of time.

The state of the art infrastructure at Emirates SkyCentral DWC is also complemented by one of the world’s largest fleet of Cool Dollys helping protect temperature sensitive cargo during transit between the aircraft and cargo terminal. Additionally, the availability of a large number of temperature controlled trucking docks and the proximity of the terminal to the aircraft parking gates will ensure rapid and efficient clearance of cargo for further distribution.

In addition to cold storage, Emirates SkyCargo will also offer dedicated zones for value-added services such as re-icing and repackaging of vaccines for global distribution for its customers.

The extensive size of the facility, which can potentially handle millions of vaccine doses, along with the creation of a dedicated team to handle and execute requests will allow Emirates SkyCargo to be able to effectively handle the large volume of time critical requests for cross-border vaccine movement that will follow the successful introduction of a vaccine.

Through a combination of scheduled and charter flights, the cargo carrier will then be able to fly the vaccines to markets where they will be most needed.

Emirates’ pharma transportation capabilities

Emirates SkyCargo is harnessing decades of experience gained from transporting temperature controlled pharmaceutical products and vaccines for global manufacturers to develop innovative solutions that will meet the challenge of distributing a potential COVID-19 vaccine globally within a short timeframe.

Since 2016, the air cargo carrier has invested substantially in its capabilities for the transportation of temperature sensitive pharmaceuticals. This included the introduction of a specialised product – Emirates Pharma - and the development of dedicated GDP certified ‘fit for purpose’ infrastructure pharma both at Dubai as well as at major origin and destination points under its pharma corridors programme that currently covers more than 30 cities. Emirates SkyCargo has moved more than a quarter million tonnes of pharmaceutical cargo in the last four years.

With its fleet of modern and efficient all wide-body aircraft and a network that currently spans more than 130 destinations across six continents, combined with the strategic geographic location of its Dubai hub, Emirates SkyCargo will be able to rapidly move vaccine shipments from manufacturing sites to the vaccine hub and then onwards to the rest of the world on a combination of scheduled and passenger flights.

Over the last few months, however, Emirates SkyCargo has worked on restoring its worldwide network and cargo connectivity with flight services restored to 75 destinations by May, 100 by July and nearly 135 destinations by early October. Emirates SkyCargo’s network covers all major pharmaceutical clusters and manufacturing locations, facilitating the eventual transportation of the COVID-19 vaccine once manufacturing commences.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.